Replimune
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.About REPL
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer.
REPL Key Statistics
Stock Snapshot
Replimune(REPL) stock is priced at $7.75, giving the company a market capitalization of 640.76M. It carries a P/E multiple of -2.16.
On 2026-02-07, Replimune(REPL) stock traded between a low of $6.89 and a high of $7.80. Shares are currently priced at $7.75, which is +12.5% above the low and -0.6% below the high.
Replimune(REPL) shares are trading with a volume of 1.68M, against a daily average of 1.17M.
In the last year, Replimune(REPL) shares hit a 52-week high of $14.80 and a 52-week low of $2.68.
In the last year, Replimune(REPL) shares hit a 52-week high of $14.80 and a 52-week low of $2.68.
REPL News
Replimune Group ( (REPL) ) has provided an update. On January 29, 2026, Replimune Group amended its loan and security agreement with Hercules Capital, extendin...
“We have been engaged with the FDA in the review of the BLA resubmission for RP1,” said Sushil Patel, Ph.D., CEO of Replimune (REPL). “Advanced melanoma patient...